2228 — QuantumPharm Cashflow Statement
0.000.00%
Last trade - 00:00- HK$19.04bn
- HK$30.92bn
- CNY174.42m
Annual cashflow statement for QuantumPharm, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -2,137 | -1,439 | -1,906 |
| Depreciation | |||
| Amortisation | |||
| Non-Cash Items | 1,841 | 963 | 1,231 |
| Unusual Items | |||
| Equity in Net Earnings/Losses | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 19.7 | -22.4 | -13.5 |
| Change in Accounts Receivable | |||
| Change in Other Assets | |||
| Change in Payable / Accrued Expenses | |||
| Change in Other Liabilities | |||
| Cash from Operating Activities | -254 | -429 | -568 |
| Capital Expenditures | -164 | -199 | -131 |
| Purchase of Fixed Assets | |||
| Purchase / Acquisition of Intangibles | |||
| Other Investing Cash Flow Items | 93.2 | -2,559 | 866 |
| Sale of Fixed Assets | |||
| Sale/Maturity of Investment | |||
| Purchase of Investments | |||
| Sale of Intangible Assets | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -70.5 | -2,758 | 736 |
| Financing Cash Flow Items | -1.68 | 66.6 | -1.55 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 2,476 | 58 | -25.9 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 2,093 | -2,949 | 137 |